128 related articles for article (PubMed ID: 8149187)
1. Distinction between focally accelerated bone formation and osteomalacia in carcinoma of prostate metastasised to bone.
Taube T; Beneton MN; Williams JL; McCloskey EV; Kanis JA
Br J Urol; 1993 Jul; 72(1):98-103. PubMed ID: 8149187
[TBL] [Abstract][Full Text] [Related]
2. Osteoblast function and osteomalacia in metastatic prostate cancer.
Clarke NW; McClure J; George NJ
Eur Urol; 1993; 24(2):286-90. PubMed ID: 8375452
[TBL] [Abstract][Full Text] [Related]
3. [Prostatic osteocondensing metastases. The value of examining for osteomalacia].
Mage P; Coindre JM; Goussot JF; Ballanger P; Lamarche P
Ann Urol (Paris); 1985; 19(3):203-6. PubMed ID: 4040729
[TBL] [Abstract][Full Text] [Related]
4. [Prostatic osteocondensing metastases and osteomalacia. Value of histomorphometric study. Preliminary results].
Coindre JM; Mage P; Bui BN; Goussot JF; De Mascarel I; De Mascarel A; Trojani M
Presse Med; 1985 Oct; 14(35):1823-7. PubMed ID: 2933667
[TBL] [Abstract][Full Text] [Related]
5. Generalised increase in bone resorption in carcinoma of the prostate.
Urwin GH; Percival RC; Harris S; Beneton MN; Williams JL; Kanis JA
Br J Urol; 1985 Dec; 57(6):721-3. PubMed ID: 4084733
[TBL] [Abstract][Full Text] [Related]
6. Biochemical and histological evidence that carcinoma of the prostate is associated with increased bone resorption.
Percival RC; Urwin GH; Harris S; Yates AJ; Williams JL; Beneton M; Kanis JA
Eur J Surg Oncol; 1987 Feb; 13(1):41-9. PubMed ID: 3102281
[TBL] [Abstract][Full Text] [Related]
7. [Semiology and classification of the different types of osteopenia: osteoporosis, osteomalacia and tumoral osteolysis (author's transl)].
Nagant de Deuxchaisnes C; Devogelaer JP; Rombouts-Lindemans C
J Belge Rhumatol Med Phys; 1973 Sep; 28(5):187-236. PubMed ID: 4794039
[No Abstract] [Full Text] [Related]
8. The effect of clodronate on bone in metastatic prostate cancer. Histomorphometric report of a double-blind randomised placebo-controlled study.
Taube T; Kylmälä T; Lamberg-Allardt C; Tammela TL; Elomaa I
Eur J Cancer; 1994; 30A(6):751-8. PubMed ID: 7917532
[TBL] [Abstract][Full Text] [Related]
9. Osteomalacia associated with prostatic cancer and osteoblastic metastases.
Kabadi UM
Urology; 1983 Jan; 21(1):65-7. PubMed ID: 6687413
[TBL] [Abstract][Full Text] [Related]
10. Oncogenic osteomalacia associated with metastatic prostate carcinoma: case report and review of the literature.
McMurtry CT; Godschalk M; Malluche HH; Geng Z; Adler RA
J Am Geriatr Soc; 1993 Sep; 41(9):983-5. PubMed ID: 8409185
[No Abstract] [Full Text] [Related]
11. Sclerotic bone metastases of prostatic origin and osteomalacia. Importance of a histomorphometry study.
Bürki F; Coindre JM; Mauriac L
Prog Clin Biol Res; 1987; 243A():569-71. PubMed ID: 3659014
[No Abstract] [Full Text] [Related]
12. A man with osteoblastic metastasis and hypocalcaemia.
Lim SC; Tan CE; Aw TC; Khoo D; Eng P; Ho SC; Tai ES; Fok A
Singapore Med J; 2000 Feb; 41(2):74-6. PubMed ID: 11063207
[TBL] [Abstract][Full Text] [Related]
13. Morphometric evidence for bone resorption and replacement in prostate cancer.
Clarke NW; McClure J; George NJ
Br J Urol; 1991 Jul; 68(1):74-80. PubMed ID: 1873694
[TBL] [Abstract][Full Text] [Related]
14. Bisphosphonates in prostate carcinoma.
Adami S
Cancer; 1997 Oct; 80(8 Suppl):1674-9. PubMed ID: 9362435
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the effect of oral clodronate on skeletal metastases with type 1 collagen metabolites. A controlled trial of the Finnish Prostate Cancer Group.
Kylmälä T; Tammela T; Risteli L; Risteli J; Taube T; Elomaa I
Eur J Cancer; 1993; 29A(6):821-5. PubMed ID: 7683480
[TBL] [Abstract][Full Text] [Related]
16. Markers of bone turnover in prostate cancer.
Garnero P
Cancer Treat Rev; 2001 Jun; 27(3):187-92; discussion 193-6. PubMed ID: 11417970
[TBL] [Abstract][Full Text] [Related]
17. Skeletal effects of carcinoma of the breast and prostate.
Percival RC
Ann R Coll Surg Engl; 1986 Sep; 68(5):267-70. PubMed ID: 3789624
[TBL] [Abstract][Full Text] [Related]
18. Does increased local bone resorption secondary to breast and prostate cancer result in increased cartilage degradation?
Leeming DJ; Byrjalsen I; Qvist P; Koizumi M; Lynnerup N; Fregerslev M; Sørensen MG; Christiansen C; Karsdal MA
BMC Cancer; 2008 Jun; 8():180. PubMed ID: 18588674
[TBL] [Abstract][Full Text] [Related]
19. Histomorphometric analysis of sclerotic bone metastases from prostatic carcinoma special reference to osteomalacia.
Charhon SA; Chapuy MC; Delvin EE; Valentin-Opran A; Edouard CM; Meunier PJ
Cancer; 1983 Mar; 51(5):918-24. PubMed ID: 6681595
[TBL] [Abstract][Full Text] [Related]
20. Low prevalence of osteomalacia in elderly patients with hip fracture.
Compston JE; Vedi S; Croucher PI
Age Ageing; 1991 Mar; 20(2):132-4. PubMed ID: 2053503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
